Difference between revisions of "Kidney tumours"

Jump to navigation Jump to search
590 bytes added ,  21:02, 16 May 2013
Line 686: Line 686:
Features:<ref name=pmid21602815/>
Features:<ref name=pmid21602815/>
*CK7 +ve.
*CK7 +ve.
**Usu. -ve in clear cell RCC.
**Usually -ve in clear cell RCC.
*CD10 -ve.
*CD10 -ve.
**Usu. +ve in clear cell RCC.
**Usually +ve in clear cell RCC.
**Positive in Xp11.2 translocation carcinoma.<ref name=pmid21804394>{{Cite journal  | last1 = He | first1 = H. | last2 = Zhou | first2 = GX. | last3 = Zhou | first3 = M. | last4 = Chen | first4 = L. | title = The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. | journal = Int J Gynecol Pathol | volume = 30 | issue = 5 | pages = 425-30 | month = Sep | year = 2011 | doi = 10.1097/PGP.0b013e318214dd4f | PMID = 21804394 }}</ref>
*TFE3 -ve.
*TFE3 -ve.
**By definition +ve in [[Xp11.2 translocation carcinoma]].
**By definition +ve in [[Xp11.2 translocation carcinoma]].
48,836

edits

Navigation menu